Source Naturals, DL Phenylalanine, 375mg, 120 ct

DL-Phenylalanine, or DLPA, is a 50/50 mixture of the D- and L- forms of the amino acid phenylalanine (phenylalanine is one of the few aminos that can be utilized in its D- form). Researchers believe that D-phenylalanine (DPA) inhibits the action of an enzyme that breaks down endorphins and enkephalins. These are proteins that bind to opioid receptor sites in the brain, thereby influencing the perception of minor discomfort that is associated with normal physiological processes. By obstructing the action of this enzyme, DPA may extend the life of endorphins and enkephalins and their positive influence on comfort levels. L-Phenylalanine is the predecessor to two neurotransmitters that help support an alert state.

Packaging

120 tabs

Suggested Use

1 to 2 tablets 1 to 2 times daily.

Ingredients

Calcium - 86 mg
DL-Phenylalanine - 750 mg

Other Ingredients: dibasic calcium phosphate, glucitol, stearic acid, magnesium stearate, colloidal silicon dioxide, and modified cellulose gum.

About Source Naturals

Source Naturals was created in 1982 to support each individual's potential to enjoy optimal health. Source Naturals' comprehensive Bio-Aligned Formulas help bring the power of alignment to your body. When formulating, we evaluate the underlying causes of system imbalances, and then provide targeted nutrition to interdependent body systems. Our line of more than 600 products also includes well-researched, single entity nutrients in their highest quality and most bioavailable forms.

Safety

Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.

Disclaimer

Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.